Discover
CCEL
Cryo-Cell International, Inc.
4.36
300 x 3.23
100 x 4.75
bid
ask
+
0.19
4.56%
200 @ 04:00 PM
4.36 +0.00 (0.00%)
| Ytd | 26.74% | |
| 1y | -1.36% |
4.10
day range
4.47
2.89
52 week range
4.57
| Open | 4.00 | Prev Close | 4.17 | Low | 4.10 | High | 4.47 | Mkt Cap | 35.15M |
| Vol | 5.47K | Avg Vol | 24.02K | EPS | -0.31 | P/E | N/A | Forward P/E | 96.63 |
| Beta | 0.51 | Short Ratio | 0.51 | Inst. Own | 11.18% | Dividend | 1.00 | Div Yield | 12.77 |
| Ex Div Date | 11-15 | Earning | 07-18 | 50-d Avg | 4.01 | 200-d Avg | 3.59 | 1yr Est | 9.00 |
| Income Statement | |||
| Total Revenue | 7.82M | ||
| Revenues (USD) | 7.82M | ||
| Cost of Revenue | 1.61M | ||
| Gross Profit | 6.21M | ||
| Operating Expenses | 4.02M | ||
| Research and Development Expense | 53.62K | ||
| Selling, General and Administrative Expense | 3.78M | ||
| Operating Income | 2.19M | ||
| Interest Expense | 438.31K | ||
| Income Tax Expense | 554.96K | ||
| Net Income | 1.27M | ||
| Net Income Common Stock | 1.27M | ||
| Net Income Common Stock (USD) | 1.27M | ||
| Consolidated Income | 1.27M | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 2.26M | ||
| Earning Before Interest & Taxes (USD) | 2.26M | ||
| Weighted Average Shares | 8.06M | ||
| Weighted Average Shares Diluted | 8.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.43M | ||
| Cash and Equivalents (USD) | 1.43M | ||
| Investments | 2.80M | ||
| Investments Current | 2.80M | ||
| Trade and Non-Trade Receivables | 6.83M | ||
| Current Assets | 13.17M | ||
| Property, Plant & Equipment Net | 21.07M | ||
| Total Assets | 62.30M | ||
| Debt Current | 626.04K | ||
| Total Debt | 8.82M | ||
| Current Liabilities | 15.33M | ||
| Debt Non-Current | 8.19M | ||
| Total Liabilities | 78.70M | ||
| Accumulated Retained Earnings (Deficit) | -36.57M | ||
| Shareholders Equity | -16.39M | ||
| Shareholders Equity (USD) | -16.39M | ||
| Assets Non-Current | 49.13M | ||
| Total Debt (USD) | 8.82M | ||
| Deferred Revenue | 63.97M | ||
| Goodwill and Intangible Assets | 2.77M | ||
| Inventory | 1.23M | ||
| Liabilities Non-Current | 63.37M | ||
| Trade and Non-Trade Payables | 2.42M | ||
| Tax Assets | 23.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 333.44K | ||
| Net Cash Flow from Financing | -42.66K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 918.36K | ||
| Capital Expenditure | -101.88K | ||
| Issuance (Repayment) of Debt Securities | -42.66K | ||
| Net Cash Flow from Investing | -180.75K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -78.87K | ||
| Net Cash Flow from Operations | 1.14M | ||
| Share Based Compensation | 92.51K | ||